Molecular & cellular oncology

Keyphrases

Publications

volume 10, number 1, 2023

Eric A Sosa, Edward M De Robertis
The developmental gene Chordin is amplified and expressed in human cancers. Molecular & cellular oncology 10 (1) (2023)
Dalila Luciola Zanette, Karoline Brito Caetano Andrade Coelho, Eneas de Carvalho, Mateus Nobrega Aoki, Jeanine Marie Nardin, Larissa Araújo Lalli, Rafael Dos Santos Bezerra, Marta Giovanetti, Victória Simionatto Zucherato, Gabriel Montenegro de Campos, Jardelina de Souza Todão Bernardino, Vincent Louis Viala, Massimo Ciccozzi, Luiz Carlos Junior Alcantara, Sandra Coccuzzo Sampaio, Maria Carolina Elias, Simone Kashima, Dimas Tadeu Covas, Svetoslav Nanev Slavov
Metagenomic insights into the plasma virome of Brazilian patients with prostate cancer. Molecular & cellular oncology 10 (1) (2023)
Akshay Pratap, Andrea Qualman, Hedlund Garrett, Lindsey Westbrook, Erlinda The, Sanchayita Mitra, Mila Cordero, Kenneth Meza Monge, Juan-Pablo Idrovo, Argudit Chauhan, Linling Cheng, Mitchell Jay Cohen, Benedetto Mungo, Sachin Wani, Robert Alexander Meguid, Martin D McCarter, Xianzhong Meng
Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma. Molecular & cellular oncology 10 (1) (2023)
Zahra Farsi, Najaf Allahyari Fard
The identification of key genes and pathways in glioblastoma by bioinformatics analysis. Molecular & cellular oncology 10 (1) (2023)
Dalila Luciola Zanette, Karoline Brito Caetano Andrade Coelho, Eneas de Carvalho, Mateus Nobrega Aoki, Jeanine Marie Nardin, Larissa Araújo Lalli, Rafael Dos Santos Bezerra, Marta Giovanetti, Victória Simionatto Zucherato, Gabriel Montenegro de Campos, Jardelina de Souza Todão Bernardino, Vincent Louis Viala, Massimo Ciccozzi, Luiz Carlos Junior Alcantara, Sandra Coccuzzo Sampaio, Maria Carolina Elias, Simone Kashima, Dimas Tadeu Covas, Svetoslav Nanev Slavov
Metagenomic insights into the plasma virome of Brazilian patients with prostate cancer. Molecular & cellular oncology 10 (1) (2023)

volume 9, number 1, 2022

Manuel Beltran, Francesca Rossi, Irene Bozzoni
CircZNF609 as a prototype to elucidate the biological function of circRNA-mRNA interactions. Molecular & cellular oncology 9 (1) (2022)
Daria Capece, Guido Franzoso
Rewired lipid metabolism as an actionable vulnerability of aggressive colorectal carcinoma. Molecular & cellular oncology 9 (1) (2022)
Amir Yarahmadi, Romoye Sohan, Brenna McAllister, Leslie Ann Caromile
Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target. Molecular & cellular oncology 9 (1) (2022)
Gaurav Mendiratta, Michael K Jones, Edward Cooper Stites
How often is each gene mutated within the cancer patient population? Molecular & cellular oncology 9 (1) (2022)
François Ghiringhelli
MAPK signaling regulates the efficacy of chemoimmunotherapy. Molecular & cellular oncology 9 (1) (2022)
Chandrani Mukhopadhyay, Pengbo Zhou
G3BP1 modulates SPOP to promote prostate tumorigenesis. Molecular & cellular oncology 9 (1) (2022)
Ma de Lourdes Zuñiga Martinez, Carlos Miguel López Mendoza, Jared Tenorio Salazar, Alejandro Manuel García Carrancá, Marco Antonio Cerbón Cervantes, Luz Eugenia Alcántara-Quintana
Establishment, authenticity, and characterization of cervical cancer cell lines. Molecular & cellular oncology 9 (1) (2022)
Han Han, Alisa Mahieu, Lucas Dantas de Paula, Wenqi Wang
Functional interplay between the Hippo pathway and heavy metals. Molecular & cellular oncology 9 (1) (2022)
Priyanka Bansal, Christoph F Kurat
Yta7, a chromatin segregase regulated by the cell cycle machinery. Molecular & cellular oncology 9 (1) (2022)
Younghoon Kee, Jung-Hee Lee, Ho Jin You
RAD51 wrestles with SUMO. Molecular & cellular oncology 9 (1) (2022)
Christos P Zampetidis, Argyris Papantonis, Vassilis G Gorgoulis
Escape from senescence: revisiting cancer therapeutic strategies. Molecular & cellular oncology 9 (1) (2022)
Marjorie Lapouge, Sylvain Meloche
YES, a novel therapeutic target in hepatocellular carcinoma. Molecular & cellular oncology 9 (1) (2022)
Giorgia Foggetti, Chuan Li, Hongchen Cai, Dmitri A Petrov, Monte M Winslow, Katerina Politi
Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment. Molecular & cellular oncology 9 (1) (2022)
Mercedes Blanco-Benítez, Ana Calderón-Fernández, Saray Canales-Cortés, Eva Alegre-Cortés, Elisabet Uribe-Carretero, Marta Paredes-Barquero, Alberto Gimenez-Bejarano, Gema Duque González, Patricia Gómez-Suaga, Juan Ortega-Vidal, Sofía Salido, Joaquín Altarejos, Guadalupe Martínez-Chacón, Mireia Niso-Santano, José M Fuentes, Rosa A González-Polo, Sokhna M S Yakhine-Diop
Biological effects of olive oil phenolic compounds on mitochondria. Molecular & cellular oncology 9 (1) (2022)
Georg A Busslinger
Barrett's esophagus stages: their correlation with SBS17-associated DNA mutations and the identification of histological marker genes. Molecular & cellular oncology 9 (1) (2022)
Ganapathy Sriram, Tiffany R Emmons, Lauren E Milling, Darrell J Irvine, Michael B Yaffe
Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade. Molecular & cellular oncology 9 (1) (2022)
Aziz M Rangwala, Benedict-Tilmann Berger, Matthew B Robers, Stefan Knapp, Markus A Seeliger
Resistance to kinase inhibition through shortened target engagement. Molecular & cellular oncology 9 (1) (2022)

volume 8, number 6, 2022

Evangelos Pazarentzos
Cell demise inhibited: Unexpected liaisons between mitochondria and IκΒα. Molecular & cellular oncology 8 (6) (2022)

volume 8, number 5, 2021

Bi Shi, Wei Li, Hao Jiang
Epigenetic condensates regulate chromatin activity and tumorigenesis. Molecular & cellular oncology 8 (5) (2021)
Christina G Towers
Mitochondrial homeostasis is maintained in the absence of autophagy. Molecular & cellular oncology 8 (5) (2021)
Aiman Sabaawy, Saman Zeeshan
Targeting the immune microenvironment during immunotherapy for solid tumors. Molecular & cellular oncology 8 (5) (2021)
Christopher J Terranova
Chromatin state profiling reveals PRC2 inhibition as a therapeutic target in NRAS-mutant melanoma. Molecular & cellular oncology 8 (5) (2021)
Afu Fu, Ido Livneh, Aaron Ciechanover, Victoria Cohen-Kaplan
How multi-component cascades operate in cells: lessons from the ubiquitin system-containing liquid-separated condensates. Molecular & cellular oncology 8 (5) (2021)
Francesca De Bacco, Carla Boccaccio
ERBB3 as a therapeutic target in glioblastoma: overexpression can make the difference. Molecular & cellular oncology 8 (5) (2021)
Ana Ortega-Molina, Alejo Efeyan
From mouse genetics to targeting the Rag GTPase pathway. Molecular & cellular oncology 8 (5) (2021)
Joel D Pearson, Rod Bremner
Simplifying cancer: binary pan-cancer superclasses stratified by opposite YAP/TEAD effects. Molecular & cellular oncology 8 (5) (2021)
Navya Murugesan, Mayinuer Maitituoheti
KMT2D deficiency confers a therapeutic vulnerability to glycolytic and IGFR inhibitors in melanoma. Molecular & cellular oncology 8 (5) (2021)

volume 8, number 6, 2021

Christina W Yde
Aurora A and Mcl-1: new potential treatment targets in antiestrogen-resistant breast cancer. Molecular & cellular oncology 8 (6) (2021)
Andrés García-García, Ivan Martin
Biomimetic human bone marrow tissues: models to study hematopoiesis and platforms for drug testing. Molecular & cellular oncology 8 (6) (2021)
Marta Llorens-Agost, Michael Ensminger, Hang Phuong Le, Wolf-Dietrich Heyer, Markus Löbrich
Turning end-joining upside down in mitosis. Molecular & cellular oncology 8 (6) (2021)
Yuan Zhu, Wang Zheng, Emmanuelle S Jecrois, Brianna R Pierce, Daniel M Treisman
A therapeutic window for preventive therapy in NF1-associated optic pathway glioma. Molecular & cellular oncology 8 (6) (2021)
Mariana Paes Dias, Jos Jonkers
Filling in the gaps in PARP inhibitor-induced synthetic lethality. Molecular & cellular oncology 8 (6) (2021)
Casey G Langdon, Mark E Hatley
The perfect PTEN - transcriptional regulation by PTEN dictates sarcoma identity. Molecular & cellular oncology 8 (6) (2021)
Stefan Fröhling
Interdisciplinary team science to understand and intercept rare cancers. Molecular & cellular oncology 8 (6) (2021)
Caiyun Liu, Xinjian Li
Greasy GLUT1 maintains glioblastoma malignancy. Molecular & cellular oncology 8 (6) (2021)
Bastian Stark, Gregory M K Poon, John J Wyrick
CTCF puts a new twist on UV damage and repair in skin cancer. Molecular & cellular oncology 8 (6) (2021)
Alizée Vercauteren Drubbel, Benjamin Beck
Dedifferentiation of esophageal progenitors in metaplasia and cancer. Molecular & cellular oncology 8 (6) (2021)
Mariana Cooke
Novel insights into the RTK-dependent metastatic phenotype of KRAS-mutant lung adenocarcinoma. Molecular & cellular oncology 8 (6) (2021)
Anja Bufe, Sergio P Acebrón
Mitotic WNT: aligning chromosomes through KIF2A. Molecular & cellular oncology 8 (6) (2021)
Xavier Renaudin, Ashok R Venkitaraman
A mitochondrial response to oxidative stress mediated by unscheduled RNA-DNA hybrids (R-loops). Molecular & cellular oncology 8 (6) (2021)
Kazuhiro Fukumura, Julian P Venables, Akila Mayeda
SPF45/RBM17-dependent splicing and multidrug resistance to cancer chemotherapy. Molecular & cellular oncology 8 (6) (2021)
Amanda K Riley, Alice H Berger
Genome-wide CRISPR screening reveals novel therapeutic targets in RIT1-driven lung cancer. Molecular & cellular oncology 8 (6) (2021)
Sunghoon Kim, Andrew L Wolfe, Sung Eun Kim
Targeting cancer's sweet spot: UGP2 as a therapeutic vulnerability. Molecular & cellular oncology 8 (6) (2021)
Fabrizio Simeoni, Tim C P Somervaille
Enhancer recruitment of a RUNX1, HDAC1 and TLE3 co-repressor complex by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. Molecular & cellular oncology 8 (6) (2021)
Romain Villot, Audrey Poirier, Romain Devillers, Aliona Kolnoguz, Sabine Elowe, Venkata S K Manem, Philippe Joubert, Frédérick A Mallette, Mathieu Laplante
ZNF768: controlling cellular senescence and proliferation with ten fingers. Molecular & cellular oncology 8 (6) (2021)